Adenovirus E1A oncogene induces rereplication of cellular DNA and alters DNA replication dynamics

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8767-8778

  Singhal, Ghata ^a   Leo, Elisabetta ^b,c   Gadham Setty, Saayi Krushna ^a   Pommier, Yves ^b   Thimmapaya, Bayar ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; E1A PROTEIN; MYC PROTEIN;

ADENOVIRUS; ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; DNA REPLICATION; DNA REPLICATION ORIGIN; GENE EXPRESSION; GENE FUNCTION; GENETIC DISTANCE; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE E1A; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPLICON; VIRUS CELL INTERACTION; VIRUS ONCOGENE;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; CARCINOGENS; CELL LINE; DNA REPLICATION; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84880603273     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00879-13     Document Type: Article

References (64)

1. Berk AJ. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685.
2. Frisch SM, Mymryk JS. 2002. Adenovirus-5 E1A: paradox and paradigm. Nat. Rev. Mol. Cell Biol. 3:441-452.
3. Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE. 2009. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 106:13260-13265.
4. Liu X, Marmorstein R. 2007. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev. 21:2711-2716.
5. Harbour JW, Dean DC. 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2393-2409.
6. Wang HG, Moran E, Yaciuk P. 1995. E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J. Virol. 69:7917-7924.
7. Howe JA, Bayley ST. 1992. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A. Virology 186:15-24.
8. Grand RJ, Ibrahim AP, Taylor AM, Milner AE, Gregory CD, Gallimore PH, Turnell AS. 1998. Human cells arrest in S phase in response to adenovirus 12 E1A. Virology 244:330-342.
9. Cherubini G, Petouchoff T, Grossi M, Piersanti S, Cundari E, Saggio I. 2006. E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells. Cell Cycle 5:2244-2252.
10. Nichols GJ, Schaack J, Ornelles DA. 2009. Widespread phosphorylation of histone H2AX by species C adenovirus infection requires viral DNA replication. J. Virol. 83:5987-5998.
11. Cadoret JC, Meisch F, Hassan-Zadeh V, Luyten I, Guillet C, Duret L, Quesneville H, Prioleau MN. 2008. Genome-wide studies highlight indirect links between human replication origins and gene regulation. Proc. Natl. Acad. Sci. U. S. A. 105:15837-15842.
12. Karnani N, Taylor CM, Malhotra A, Dutta A. 2010. Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection. Mol. Biol. Cell 21:393-404.
13. Meáchali M. 2010. Eukaryotic DNA replication origins: many choices for appropriate answers. Nat. Rev. Mol. Cell Biol. 11:728-738.
14. Machida YJ, Hamlin JL, Dutta A. 2005. Right place, right time, and only once: replication initiation in metazoans. Cell 123:13-24.
15. Masai H, Matsumoto S, You Z, Yoshizawa-Sugata N, Oda M. 2010. Eukaryotic chromosome DNA replication: where, when, and how? Annu. Rev. Biochem. 79:89-130.
16. Alabert C, Groth A. 2012. Chromatin replication and epigenome maintenance. Nat. Rev. Mol. Cell Biol. 13:153-167.
17. Symeonidou IE, Taraviras S, Lygerou Z. 2012. Control over DNA replication in time and space. FEBS Lett. 586:2803-2812.
18. Ilves I, Petojevic T, Pesavento JJ, Botchan MR. 2010. Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins. Mol. Cell 37:247-258.
19. Jin J, Arias EE, Chen J, Harper JW, Walter JC. 2006. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol. Cell 23:709-721.
20. Abbas T, Dutta A. 2011. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle 10:241-249.
21. Conti C, Caburet S, Schurra C, Bensimon A. 2001. Molecular combing. Curr. Protoc. Cytom. 8:10.1-8:10.23.
22. Schurra C, Bensimon A. 2009. Combing genomic DNA for structural and functional studies. Methods Mol. Biol. 464:71-90.
23. Kolli S, Buchmann AM, Williams J, Weitzman S, Thimmapaya B. 2001. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC. Proc. Natl. Acad. Sci. U. S. A. 98:4646-4651.
24. Rajabi HN, Baluchamy S, Kolli S, Nag A, Srinivas R, Raychaudhuri P, Thimmapaya B. 2005. Effects of depletion of CREB-binding protein on c-Myc regulation and cell cycle G1-S transition. J. Biol. Chem. 280:361-374.
25. Baluchamy S, Rajabi HN, Thimmapaya R, Navaraj A, Thimmapaya B. 2003. Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity. Proc. Natl. Acad. Sci. U. S. A. 100:9524-9529.
26. Sankar N, Baluchamy S, Kadeppagari RK, Singhal G, Weitzman S, Thimmapaya B. 2008. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc. Oncogene 27:5717-5728.
27. Montell C, Fisher EF, Caruthers MH, Berk AJ. 1982. Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site. Nature 295:380-384.
28. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
29. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl. Genet. Mol. Biol. 3:Article3. doi:10.2202/1544-6115.1027.
30. (-ΔΔCt) method. Methods 25:402-408.
31. Kadeppagari RK, Sankar N, Thimmapaya B. 2009. Adenovirus transforming protein E1A induces c-Myc in quiescent cells by a novel mechanism. J. Virol. 83:4810-4822.
32. Meández J, Stillman B. 2000. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20:8602-8612.
33. Sankar N, Kadeppagari RK, Thimmapaya B.c. c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J. Biol. Chem. 284:15193-15205.
34. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075-6086.
35. Mymryk JS, Bayley ST. 1993. Multiple pathways for gene activation in rodent cells by the smaller adenovirus 5 E1A protein and their relevance to growth and transformation. J. Gen. Virol. 74:2131-2141.
36. Moran E. 1994. Cell growth control mechanisms reflected through protein interactions with the adenovirus E1A gene products. Semin. Virol. 5:327-340.
37. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK. 2008. Epigenetic reprogramming by adenovirus e1a. Science 321:1086-1088.
38. Dazard JE, Zhang K, Sha J, Yasin O, Cai L, Nguyen C, Ghosh M, Bongorno J, Harter ML. 2011. The dynamics of E1A in regulating networks and canonical pathways in quiescent cells. BMC Res. Notes 4:160. doi:10.1186/1756-0500-4-160.
39. Branzei D, Foiani M. 2010. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell Biol. 11:208-219.
40. Reinhardt HC, Yaffe MB. 2009. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 21:245-255.
41. Smith J, Tho LM, Xu N, Gillespie DA. 2010. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 108:73-112.
42. Shiloh Y. 2006. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31:402-410.
43. Baluchamy S, Sankar N, Navaraj A, Moran E, Thimmapaya B. 2007. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene 26:781-787.
44. Turnell AS, Grand RJ. 2012. DNA viruses and the cellular DNA-damage response. J. Gen. Virol. 93:2076-2097.
45. Jiang M, Zhao L, Gamez M, Imperiale MJ. 2012. Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection. PLoS Pathog. 8:e1002898. doi:10.1371/journal.ppat.1002898.
46. Sowd GA, Li NY, Fanning E. 2013. ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication. PLoS Pathog. 9:e1003283. doi:10.1371/journal.ppat.1003283.
47. Stracker TH, Carson CT, Weitzman MD. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
48. Hook SS, Lin JJ, Dutta A. 2007. Mechanisms to control rereplication and implications for cancer. Curr. Opin. Cell Biol. 19:663-671.
49. Blow JJ, Dutta A. 2005. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 6:476-486.
50. Havens CG, Walter JC. 2011. Mechanism of CRL4(Cdt2), a PCNAdependent E3 ubiquitin ligase. Genes Dev. 25:1568-1582.
51. Kim J, Feng H, Kipreos ET. 2007. C. elegans CUL-4 prevents rereplication by promoting the nuclear export of CDC-6 via a CKI-1-dependent pathway. Curr. Biol. 17:966-972.
52. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishimoto T. 2006.Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J. 25:1126-1136.
53. De Marco V, Gillespie PJ, Li A, Karantzelis N, Christodoulou E, Klompmaker R, van Gerwen S, Fish A, Petoukhov MV, Iliou MS, Lygerou Z, Medema RH, Blow JJ, Svergun DI, Taraviras S, Perrakis A. 2009. Quaternary structure of the human Cdt1-Geminin complex regulates DNA replication licensing. Proc. Natl. Acad. Sci. U. S. A. 106:19807-19812.
54. Conti C, Sacca B, Herrick J, Lalou C, Pommier Y, Bensimon A. 2007. Replication fork velocities at adjacent replication origins are coordinately modified duringDNAreplication in human cells. Mol. Biol. Cell 18:3059-3067.
55. Dang CV. 2012. MYC on the path to cancer. Cell 149:22-35.
56. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151:56-67.
57. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151:68-79.
58. Littlewood TD, Kreuzaler P, Evan GI. 2012. All things to all people. Cell 151:11-13.
59. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141:432-445.
60. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R. 2007. Nontranscriptional control of DNA replication by c-Myc. Nature 448:445-451.
61. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW. 1998. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12:2434-2442.
62. Campaner S, Amati B. 2012. Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance. Cell Div. 7:6.doi:10.1186/1747-1028-7-6.
63. Soucek L, Evan GI. 2010. The ups and downs of Myc biology. Curr. Opin. Genet. Dev. 20:91-95.
64. Hoffman B, Liebermann DA. 2008. Apoptotic signaling by c-MYC. Oncogene 27:6462-6472.